Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leukocyte telomere length change in children with obesity in the context of an isocaloric fructose restriction intervention.

Diabetology & metabolic syndrome·2025
Same author

Corrigendum to "Serum levels of visfatin and vaspin in healthy and complicated pregnancies and their association with anthropometric measures of their offspring" [Clinica Chimica Acta 568 (2025) 1-8].

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

Serum levels of visfatin and vaspin in healthy and complicated pregnancies and their association with anthropometric measures of their offspring.

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies.

Journal of clinical medicine·2024
Same author

Effect of pitavastatin treatment on PON1 lactonase activity in patients with hypercholesterolaemia.

Archives of medical sciences. Atherosclerotic diseases·2024
Same author

The chylomicron saga: time to focus on postprandial metabolism.

Frontiers in endocrinology·2024

Related Experiment Video

Updated: Jan 15, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

9.5K

Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk.

Alejandro Gugliucci1

  • 1Glycation, Oxidation and Disease Laboratory, Touro University California, Vallejo, CA 94592, USA.

Journal of Clinical Medicine
|October 16, 2025
PubMed
Summary

Time-restricted eating (TRE) offers a natural approach to managing residual cardiovascular risk by improving metabolic health. This accessible dietary strategy influences angiopoietin-like protein 4 (ANGPTL4) and lipoprotein lipase (LPL) activity, aiding in cardiovascular disease prevention.

Keywords:
ANGPTLLDLLPLLp(a)TRLVLDLapoCIIIatherogenesischylomicronsinsulin resistanceintermittent fastingliver fatremnantstime-restricted eating

More Related Videos

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

9.7K
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.8K

Related Experiment Videos

Last Updated: Jan 15, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

9.5K
Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

9.7K
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.8K

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Health
  • Nutritional Science

Background:

  • Residual cardiovascular risk (RCR) persists despite optimal LDL-C levels, driven by metabolic dysfunction, inflammation, and lipoprotein abnormalities.
  • Current treatments focus on LDL-C, but emerging strategies address underlying metabolic factors.
  • Dietary interventions like time-restricted eating (TRE) are gaining attention for their potential in managing atherosclerosis beyond lipid-lowering medications.

Purpose of the Study:

  • To explore the mechanisms by which time-restricted eating (TRE) contributes to cardiovascular and weight management benefits.
  • To hypothesize that TRE's impact on the circadian regulation of angiopoietin-like protein 4 (ANGPTL4) is a key factor in its efficacy.
  • To investigate TRE's influence on triglyceride-rich lipoprotein (TRL) metabolism and its role in reducing atherogenic remnant particles.

Main Methods:

  • The study presents a hypothesis and arguments based on existing literature regarding TRE's effects.
  • It discusses the proposed mechanisms involving ANGPTL4 regulation in adipose tissue and its impact on lipolysis.
  • It examines TRE's potential to enhance very low-density lipoprotein (VLDL) catabolism through modulation of lipoprotein lipase (LPL) activity.

Main Results:

  • TRE may inhibit adipose fatty acid uptake and stimulate fatty acid release via ANGPTL4 modulation.
  • TRE can potentially increase intravascular VLDL catabolism by muscle due to reduced competition with chylomicrons for LPL.
  • This leads to shortened VLDL residence time, reduced exposure to lipases, and decreased atherogenic remnant particles.

Conclusions:

  • TRE demonstrates potential as an accessible treatment for residual cardiovascular risk, acting through metabolic and circadian pathways.
  • Further large-scale, randomized controlled studies are needed to confirm TRE's role in RCR prevention and therapy.
  • Prioritizing research into TRE's influence on LPL modulation via ANGPTL4 and ANGPTL8 is recommended for developing natural, cost-effective therapeutic strategies.